Immunogen reported $456.72M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Amgen AMGN:US $ 18520M 865M
Astellas Pharma 4503:JP Y 923354M 15977M
AstraZeneca AZN:LN 22.65B 3.6B
Bluebird Bio BLUE:US $ 254.92M 81.6M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Emergent Biosolutions EBS:US $ 1100.3M 171.8M
Exelixis EXEL:US $ 1842.74M 8M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Immunogen IMGN:US $ 456.72M 43.28M
Intrexon XON:US $ 154.94M 1.69M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Macrogenics MGNX:US $ 218.2M 61.36M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Novartis NVS:US $ 37236M 8482M
Pfizer PFE:US $ 54420M 5273M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Seattle Genetics SGEN:US $ 2771.26M 97.94M